Status:
UNKNOWN
A Clinical Study on the Effect of Hypoglycemic Drugs on the Prognosis of Spinal Surgery in Diabetic Patients
Lead Sponsor:
Xijing Hospital
Conditions:
Diabetes Mellitus
Spinal Diseases
Eligibility:
All Genders
18-90 years
Brief Summary
Diabetes mellitus is a group of metabolic diseases caused by multiple etiologies and characterized by chronic hyperglycemia. It seriously harms human health and has become a global public health chall...
Eligibility Criteria
Inclusion
- Patients undergoing elective spinal surgery;
- Clinical diagnosis of diabetes (using the diagnostic criteria proposed by the WHO Expert Committee on Diabetes in 1999);
- Use metformin or sitagliptin;
- The age ranges from 18 to 90;
- Sign informed consent.
Exclusion
- Acute traumatic injury;
- Patients with cerebral hemorrhage, cerebral infarction, Parkinson's disease, spinal cord transverse syndrome, spinal cord hemiere syndrome, Guillan-Barre syndrome and other neurological diseases affecting patients' somatosensory and motor;
- Combined with rheumatoid arthritis, ankylosing spondylitis and other rheumatoid arthritis;
- Patients with long-term use of glucocorticoids;
- complicated with malignant tumor;
- Pregnant women;
- Suffering from schizophrenia, bipolar disorder, hysteria and other mental diseases;
- The use of two or more than two mechanisms of hypoglycemic drugs;
- Do not sign informed consent.
Key Trial Info
Start Date :
February 7 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 29 2024
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT05214235
Start Date
February 7 2022
End Date
February 29 2024
Last Update
June 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Air Force Medical University (Xijing Hospital)
Xi'an, Shaanxi, China, 710032